Disclosure Of Entity's Operating Segments [Text Block]

Sopharma AD - Filing #6175083

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Disclosure of entity's operating segments [text block]	—	—		—	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue	—	—	1 663 016 BGN	—	—	—	—	—	1 603 310 BGN	—
Depreciation and amortisation expense	—	—	52 099 BGN	—	—	—	—	—	53 187 BGN	—
Share of profit (loss) of associates and joint ventures accounted for using equity method	—	—	22 635 BGN	—	—	—	—	—	12 092 BGN	—
Tax expense (income)	—	—	8 743 BGN	—	—	—	—	—	5 871 BGN	—
Profit (loss) before tax	—	—	85 076 BGN	—	—	—	—	—	97 574 BGN	—
Profit (loss)	—	71 121 BGN	76 333 BGN	71 121 BGN	5 212 BGN	2 207 BGN	—	89 496 BGN	91 703 BGN	89 496 BGN
Assets	1 253 978 BGN	—	—	—	—	—	1 204 978 BGN	—	—	—
Liabilities	537 344 BGN	—	—	—	—	—	546 110 BGN	—	—	—
Cash flows from (used in) operating activities	—	—	110 082 BGN	—	—	—	—	—	75 963 BGN	—
Cash flows from (used in) investing activities	—	—	63 606 BGN	—	—	—	—	—	68 065 BGN	—
Cash flows from (used in) financing activities	—	—	64 342 BGN	—	—	—	—	—	156 606 BGN	—
Disclosure of products and services [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of major customers [abstract]
Disclosure of major customers [line items]